Beyond IL-17: New cytokines in the pathogenesis of HIV infection

Current Opinion in HIV and AIDS

Volumn 5, Issue 2, 2010, Pages 184-188

  Clerici, Mario ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Cytokines; HIV; Immunology; Immunotherapy

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 27; INTERLEUKIN 32; INTERLEUKIN 7; PROTEIN; RECOMBINANT INTERLEUKIN 7;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; APOPTOSIS; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LIVER; LIVER CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS LOAD; VIRUS REPLICATION;

CYTOKINES; HIV INFECTIONS; HUMANS; IMMUNOTHERAPY; LIVER;

EID: 76949098432     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328335c23c     Document Type: Review

References (48)

1. Lane HC, Depper JM, Greene WC, et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigens recognition. N Engl J Med 1985; 313:79-84.
2. Giorgi JV, Fahey JL, Smith DC, et al. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987; 138:3725-3730.
3. Miedema F, Petit AJ, Terpstra FG, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 1988; 82:1908-1916.
4. Clerici M, Stocks NI, Zajac RA, et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, HIV-seropositive patients: independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989; 84:1892-1899.
5. ClericiM, Shearer GM. Is HIV infection associated with a TH1->TH2 switch? Immunol Today 1993; 14:107-111.
6. Lynch HE, Goldberg GL, Chidgey A, et al. Thymic involution and immune reconstitution. Trends Immunol 2009; 30:366-373.
7. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity 2008; 29:848-862.
8. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008; 226:205-218.
9. Clerici M, Wynn TA, Berzofsky JA, et al. Role of interleukin-10 (IL-10) in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus (HIV-1). J Clin Invest 1994; 93:768-775.
10. Asao H, Okuyama C, Kumaki S, et al. Cutting edge: the common gammachain is an indispensable subunit of the IL-21 receptor complex. J Immunol 2001; 167:1-5.
11. Molina JM, Levy Y, Fournier I, et al. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). J Infect Dis 2009; 200:206-215.
12. Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1- infected adults through IL-7 treatment. J Clin Invest 2009; 119:997-1007.
13. Kinter AL,Godbout EJ,McNally JP, et al. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008; 181:6738-6746.
14. Dong HD, Zhu G, Tamada K, Chen LP. B7-H1 a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5:1365-1369.
15. Wang S, Zhu G, Chapoval AI, et al. Costimulation of T cells by B7-H2, a B7- like molecule that bind ICOS. Blood 2000; 96:2808-2813.
16. FreemanGJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immuno inhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192:1027-1034.
17. Latchman YE, Wood CR, Chernova T, et al. PD-L2, a novel B7 homologue, is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2:261-268.
18. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26:677-684.
19. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8:239-245.
20. Torheim EA, Ndhlovu LC, Pettersen FO, et al. Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population. Eur J Immunol 2009; 39:1280-1287.
21. Brockman MA, Kwon DS, Tighe DP, et al. IL-10 is upregulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009; 114:346-356.
22. Naickler DD, Werner L, Kormuth E, et al. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis 2009; 200:448-452.
23. Clerici M, Balotta C, Selvaggio A, et al. HIV phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996; 88:574-579.
24. Freeman GJ, Wherry EJ, Ahmed R, et al. Reinvigorating exhausted HIVspecific T cells via PD-1-PD-1 ligand blockade. J Exp Med 2006; 203: 2223-2227.
25. Petrovas C, Casazza JP, Brenchley JM, et al. PD-1 is a regulator of virusspecific CD8+ T cell survival in HIV infection. J Exp Med 2006; 203:2281-2292.
26. Trautmann L, Janbazian L, Chomont N, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nature Med 2006; 12:1198-1202.
27. Boasso A, Hardy AW, Landay AL, et al. PDL-1 upregulation on monocytes and T cells by HIV: restricted expression of type I interferon receptor by CCR5- expressing leukocytes. Clin Immunol 2008; 129:132-144.
28. Petrovas C, Price DA, Mattapallil J, et al. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 2007; 110:928-936.
29. Yves Levy and SILCAAT Sci Committee. Effect of interleukin-2 on clinical outcomes in patients with CD4+ cell count 50 to 299/mm3: primary results of the SILCAAT study. CROI 2009. Montreal, Canada, Feb 8-11, 2009, Abst 90bLB.
30. Trabattoni D, Saresella M, Biasin M, et al. B7-H1 is upregulated in HIV infection and is a novel surrogate marker of disease progression. Blood 2003; 101:2514-2520.
31. Sawa Y, Arima Y, Ogura H, et al. Hepatic interleukin-7 expression regulates T cell responses. Immunity 2009; 30:447-457.
32. Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nature Rev Immunol 2007; 7:144-154.
33. Durum SK, Mazzucchelli RI. Live from the liver: hepatocyte IL-7. Immunity 2009; 30:320-321.
34. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008; 223:20-38.
35. Sailer CA, Pott GB, Dinarello CA, et al. Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon-gamma levels. J Infect Dis 2007; 195:734-738.
36. Iannello A, Samarani S, Debbeche O, et al. Role of interleukin-18 in the development and pathogenesis of AIDS. AIDS Rev 2009; 11:115-125.
37. Iannello A, Samarani S, Debbeche O, et al. Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells. J Virol 2009; 83:5999-6010.
38. Iannello A, Tremblay C, Routy JP, et al. Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts. Viral Immunol 2008; 21:385-398.
39. Strbo N, de Armas L, Liu H, Kolber MA, et al. IL-21 augments natural killer effector functions in chronically HIV-infected individuals. AIDS 2008; 22:1551-1560.
40. White L, Krishnan S, Strbo N, et al. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood 2007; 109:3873-3880.
41. Zeng R, Spolski R, Finkelstein SE, et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med 2005; 201:139-148.
42. Yoshida H, Yoshiyuki M. Regulation of immune responses by interleukin-27. Immunol Rev 2008; 226:234-247.
43. Imamichi T, Yang J, Huang D-W, et al. IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 2008; 22:39-45.
44. Greenwell-Wild T, Vazquez N, Jin WW, et al. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 2009; 114: 1864-1874.
45. Biasin M, Piacentini L, Lo Caputo S, et al. APOBEC3G: a possible role in the resistance to HIV of HIV-exposed-seronegative individuals. J Infect Dis 2007; 195:960-964.
46. Kim SH, Han SY, Azam T, et al. Interleukin-32: a cytokine and inducer of TNF alpha. Immunity 2005; 22:131-142.
47. Nold MF, Petry-Nold CA, Pott GB, et al. Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 2008; 181:557-565.
48. Rasool ST, Tang H, Wu JM, et al. Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol Lett 2008; 117:161-167.